Identification and Characterization of Novel Proteins in Head and Neck Cancer

This study is currently recruiting participants.

Verified by Stanford University, July 2008

First Received: September 28, 2005 Last Updated: July 9, 2008 History of Changes

Sponsors and Collaborators:	Stanford University National Institutes of Health (NIH)
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00230308

Purpose

Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.

Condition
Head and Neck Cancer

MedlinePlus related topics: Cancer Head and Neck Cancer

U.S. FDA Resources

Study Type:	Observational
Study Design:	Prospective
Official Title:	Identification and Characterization of Novel Proteins in Head and Neck Cancer

Further study details as provided by Stanford University:

Estimated Enrollment:	500
Study Start Date:	April 2002

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:All patients undergoing surgery at Stanford University for head and neck cancer. Exclusion Criteria:Non-Stanford patients.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00230308

Locations

United States, California
Stanford University School of Medicine	Recruiting
Stanford, California, United States, 94305
Contact: Kosai Seng 650-725-0203 kseng@stanford.edu
Contact: Cancer Clinical Trials Office (650) 498-7061
Principal Investigator: Quynh-Thu Le
Sub-Investigator: Willard E Fee Jr
Sub-Investigator: Zijie Sun
Sub-Investigator: Jan Matthijs van de Rijn
Sub-Investigator: Dr Michael Kaplan

Sponsors and Collaborators

Stanford University

National Institutes of Health (NIH)

Investigators

Principal Investigator:

Quynh-Thu Le

Stanford University

More Information

No publications provided

Study ID Numbers:	ENT0008, 76537, ENT0008, NCT00230308
Study First Received:	September 28, 2005
Last Updated:	July 9, 2008
ClinicalTrials.gov Identifier:	NCT00230308 History of Changes
Health Authority:	United States: Food and Drug Administration; United States: Institutional Review Board

Study placed in the following topic categories:

Head and Neck Neoplasms

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Site
Head and Neck Neoplasms

ClinicalTrials.gov processed this record on May 07, 2009